Wilson Sonsini Goodrich & Rosati has advised Saturnus Bio. Merck has entered into a strategic research-stage collaboration with Saturnus Bio, a company founded by Versant Ventures,...
Merck and Versant Ventures Collaborate to Launch Saturnus Bio in Precision Cardiology
Agero to Acquire Urgently in $5.50 Per Share Cash Transaction
Morgan, Lewis & Bockius LLP has advised Agero, Inc., and Wilson Sonsini Goodrich & Rosati has advised Urgently. Agero, Inc., a leading provider of software-enabled driver...
Tenaya Therapeutics Completes $60 Million Units Offering
Davis Polk & Wardwell LLP has advised the joint book-running managers and representatives of the underwriters. Goodwin Procter LLP has served as outside intellectual property counsel...
Epsilogen’s Acquisition of TigaTx
Wilson Sonsini Goodrich & Rosati advised TigaTx on the transaction. Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, announced that it...
Microchip Technology’s $1.48 Billion of Depositary Shares
Wilson Sonsini Goodrich & Rosati represented Microchip Technology on the transaction, and Davis Polk & Wardwell represented the underwriters. Microchip Technology Incorporated (MCHP) completed a mandatory...
Prudentia Sciences’ $7 Million Funding Round
Wilson Sonsini Goodrich & Rosati advised Prudentia Sciences on the transaction. Prudentia Sciences, an AI-powered technology platform for life sciences, emerged from stealth supported by $7...
BioSapien’s $5.5 Million Pre-Series A Funding Round
Wilson Sonsini Goodrich & Rosati advised BioSapien on the transaction. BioSapien, an Abu Dhabi-based biotech startup focused on drug delivery for localized cancer treatment, announced the...
Lumos Pharma’s Tender Offer and Merger with Double Point Ventures
Wilson Sonsini Goodrich & Rosati and Cooley advised Lumos Pharma on the transaction, while Foley & Lardner advised Double Point Ventures. Lumos Pharma (NASDAQ:LUMO), a clinical...
Microchip Technology’s $1 Billion Senior Notes Offering
Wilson Sonsini Goodrich & Rosati represented Microchip Technology Incorporated in the offering, and Simpson Thacher & Bartlett represented the underwriters. Microchip Technology Incorporated (Microchip) (Nasdaq: MCHP) priced...
Tenaya Therapeutics’ $50 Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya Therapeutics on the transaction, and Davis Polk & Wardwell advised the underwriters. Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage...
ThayerMahan’s $20 Million Series C Funding Round
Wilson Sonsini Goodrich & Rosati advised ThayerMahan, Inc. on the transaction. ThayerMahan, Inc. announced it closed $20 million in follow-on Series C funding led by Hanwha Asset...
Nature’s Toolbox’s $47.5 Million Series B Funding Round
Wilson Sonsini Goodrich & Rosati advised Nature’s Toolbox on the transaction. Nature’s Toolbox (NTx) announced the close of a $47.5 million Series B funding round led by...